At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
KEYTRUDA is the first and only immunotherapy-based regimen to show a statistically significant and clinically meaningful improvement in overall survival
Subscribe To Our Newsletter & Stay Updated
